byiShook Opinion
Mar 24, 2025 - 11:55
Novo Nordisk stock dropped Monday after the drugmaker licensed a Chinese competitor's weight-loss drug for $200 million up front. The post Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble. appeared first on Investor's Business Daily.
Novo Nordisk stock dropped Monday after the drugmaker licensed a Chinese competitor's weight-loss drug for $200 million up front.
The post Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble. appeared first on Investor's Business Daily.